COLO-B Coloplast A/S

73.30USD499.50 DKK · CPH-0.54%Mkt Cap: 16.52B USDP/E: 36.62

Coloplast A/S develops and sells intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through five segments: Chronic Care, Voice &…

Institutional holders11 on file

Key Statistics

Company
Market Cap16.52B USD
Enterprise Value19.69B USD
Revenue (TTM)4.25B USD
Gross Profit2.82B USD
Net Income (TTM)451.08M USD
Revenue/Share18.84 USD
Last Price73.30 USD
Fiscal Year EndSep 2026
MR QuarterSep 2026
Employees17.3K
CountryDK
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINDK0060448595
Valuation
P/E (Trailing)36.62
P/E (Forward)18.58
PEG0.98
EV/EBITDA15.94
EV/Revenue4.64
P/S3.89
P/B7.88
EPS (TTM)2.00 USD
EPS (Forward)3.94 USD
52W Range
54.2550% of range92.65
52W High92.65 USD
52W Low54.25 USD
Profitability
Gross Margin66.50%
Oper. Margin25.73%
EBITDA Margin29.08%
Profit Margin10.62%
ROE21.51%
ROA6.64%
ROIC16.85%
ROCE22.70%
Growth
Revenue Growth7.20%
Earnings Growth35.60%
Cash Flow & Leverage
Operating CF1.17B USD
CapEx (TTM)230.38M USD
FCF Margin22.99%
FCF Yield5.91%
Net Debt3.08B USD
Net Debt/EBITDA2.50
Net Debt/FCF3.16
Balance Sheet
Debt/Equity1.51
Current Ratio0.74
Quick Ratio0.41
Book Value/Sh9.31 USD
Cash/Share0.33 USD
Dividends
Fwd Div Rate3.38 USD
Trail. Div Rate3.38 USD
Div. Yield4.58%
5Y Avg Yield2.73%
Payout Ratio168.62%
Ex-Div DateMay 18, 2026
Pay Date—
Splits
Last Split5:1
Split DateDec 19, 2012
Analyst Consensus
Rating3.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)69.53 USD
Upside (mean)-5.1%
Target Range55.03 USD – 88.04 USD
55.03-5.1% to mean88.04
# Analysts21
Ownership
Shares Out.207.37M
Float144.70M
Insiders29.79%
Institutions29.84%
Technical
SMA 5066.68 (+9.9%)
SMA 20063.71 (+15.1%)
Beta0.57
S&P 52W Chg12.08%
Avg Vol (30d)384.87K
Avg Vol (10d)545.04K
Technical Indicators
RSI (14)57.2
MACD12.1023
MACD Signal13.9983
MACD Hist.-1.8960
BB Upper77.06 USD
BB Middle72.75 USD
BB Lower68.43 USD
BB Width11.87%
ATR (14)1.989 USD
Vol Ratio (20d)0.69x

About Coloplast (CPH: COLO-B)

›

Coloplast (CPH: COLO-B) is listed on Nasdaq Copenhagen, where its shares trade in DKK. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 17,270 employees.

The shares were at 499.50 DKK on 19 November 2026, down 6.4% over 52 weeks. Its 52-week range is 369.70 DKK to 631.40 DKK: the price is 20.9% below the high and 35.1% above the low.

At a market capitalisation of 112.57B DKK, it trades at 36.6 times trailing earnings and 18.6 times forward earnings. The median trailing P/E of its 18 largest Medical Instruments & Supplies peers is 51.8, a discount of 29% for COLO-B. It pays a dividend yielding 4.58% (it pays out 169% of its earnings), against a median of 0.71% among the dividend payers in that peer group.

Coloplast reports return on equity of 21.5%, an operating margin of 25.7% and revenue up 7.2% year over year.

Its debt exceeds its cash by 21.01B DKK, a debt-to-equity ratio of 1.51. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 21 analysts cover the stock, with an average rating of Hold; their mean price target of 473.81 DKK is 5.1% below the current price. The next earnings report is expected on 9 February 2027.